Dr. Cemal Yazici, MD

Dr. Yazici practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Yazici's NPI, 1295039865, was assigned on December 22, 2010. Dr. Yazici holds Illinois license 036.128567.

Dr. Yazici's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Yazici's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Yazici to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yazici practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Yazici's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Yazici is licensed in Illinois.

CMS data shows 29 Medicare services from Dr. Yazici across 2 procedure codes in 2024, for 62 Medicare patients. Medicare paid $3,087 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 62 Medicare patients who saw Dr. Yazici in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yazici's median patient age at 67, with 64% women.

In 2024, Dr. Yazici wrote 49 Medicare Part D claims for 27 patients. 76% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $84 in total drug cost. In 2023, CMS named 27 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Yazici for performance year 2024, reported as part of a group. Dr. Yazici accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Yazici, more than 45% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 45 papers to Dr. Yazici, published from 2011 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Pancreatitis, Pancreas and Tomography, X-Ray Computed. Dr. Yazici has published most often in Pancreas. Dr. Yazici's most frequent co-authors are Barbara Hedwig Jung, MD, Georgios I. Papachristou, MD and Peter Lee, MD.

CMS Open Payments shows 17 general payments to Dr. Yazici from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Abbvie Inc. paid the most, $940.